I reckon a bit high on the valuations but we don't talk big...

I reckon a bit high on the valuations but we don't talk big numbers here. No one will be disappointed if that were to occur, but we would form one hell of a base regardless.

It is hard to guage this third time but I have liked the more methodical way that announcements have been massaged. Much more scientific positivity as it were, confidence sure, but seemingly backed up with health care professionals sentiments. Maybe that's my interpretations from the last year of the antibiotic story. Throwing in the idea of the books in the library wasn't too shabby either allowing future expansion possibilities within the patented framework.

I am as excited as a eunuch in a harem at the moment. I can see what's happening, I understand what they are doing but I can't do a thing about it.

A third time luckiest frontal LaBOT to me would make the wait totally worthwhile.

BUONA FORTUNA AMICI